NCT02256865View on ClinicalTrials.gov

Hormonal Mechanisms of Sleep Restriction

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

October 31, 2023

Conditions
Insulin Resistance
Interventions
DRUG

Ketoconazole

Ketoconazole is taken 4 times a day

DRUG

Hydrocortisone

Hydrocortisone is taken 3 times a day

DRUG

Testosterone

Testosterone gel is applied once a day

DRUG

Placebo for ketoconazole

Placebo for ketoconazole

DRUG

Placebo for hydrocortisone

Placebo for hydrocortisone

DRUG

Placebo for testosterone

Placebo for testosterone

Trial Locations (1)

90509

Los Angeles Biomedical Research Institute, Torrance

All Listed Sponsors
lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

NCT02256865 - Hormonal Mechanisms of Sleep Restriction | Biotech Hunter | Biotech Hunter